JANX Q1 2025 Earnings — Janux Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

JANXJanux Therapeutics, Inc.

$852M

Q1 2025 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0-100.0% YoY

Gross Profit

$0

Operating Income

-$35M

Net Income

-$24M

EPS (Diluted)

$-0.38

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

-$17M

Free Cash Flow

-$17M

Stock-Based Comp.

$11M

Balance Sheet

Total Assets

$1.1B

Total Liabilities

$38M

Stockholders' Equity

$1.0B

Cash & Equivalents

$74M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$1M	-100.0%
Gross Profit	$0	$720,000	-100.0%
Operating Income	-$35M	-$20M	-73.1%
Net Income	-$24M	-$15M	-59.3%